Stockholm - Delayed Quote SEK
OncoZenge AB (publ) (ONCOZ.ST)
At close: 3:51 PM GMT+1
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Stian Kildal | Chief Executive Officer | -- | -- | -- |
| Mr. Michael Owens B.A., B.S., B.S.B.A | Chief Financial Officer | -- | -- | 1956 |
OncoZenge AB (publ)
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 2
Description
OncoZenge AB (publ), a pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of pain in the oral cavity. The company was incorporated in 2020 and is headquartered in Bromma, Sweden.
Corporate Governance
OncoZenge AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
EGTX.ST Egetis Therapeutics AB (publ)
4.1000
-0.97%
ELIC.ST Elicera Therapeutics AB (publ)
1.9050
-3.54%
FLERIE.ST Flerie AB (publ)
44.47
-1.32%
ALZ.ST Alzinova AB (publ)
3.4400
-3.37%
STABL.ST Stayble Therapeutics AB (publ)
0.7200
-3.36%
IRLAB-A.ST IRLAB Therapeutics AB (publ)
13.65
-2.15%
VICO.ST Vicore Pharma Holding AB (publ)
7.95
-0.63%
BINV.ST BioInvent International AB (publ)
45.00
-1.10%
PILA.ST Pila Pharma AB (publ)
4.6700
-2.71%
ISOFOL.ST Isofol Medical AB (publ)
3.3300
-4.86%